ABSTRACT
Background Mendelian randomization (MR) has emerged as a valuable tool for causal inference in genetic epidemiology. Existing MR methods have issues related to pleiotropy and offer limited comprehensiveness. Here, we introduce an integrated MR analysis pipeline designed for GWAS summary statistics data. Our pipeline integrates feature selection, harmonization, and checkpoint mechanisms to improve the accuracy and reliability of MR analysis.
Methods In classical GWAS, the p-value threshold usually does not guarantee to identify causal single-nucleotide polymorphisms (SNPs). In such cases, t-statistics can be considered as imperative and robust criteria for identifying causal SNPs. Therefore, in this study, we computed the t-statistic for all independent SNPs remained after linkage disequilibrium pruning. Next, prior to harmonization, we removed SNPs having a t-statistic below the average t-statistic value. Furthermore, our pipeline incorporates sensitivity analysis tests at each step to reduce the chances of directional pleiotropy.
Result and Conclusion We applied our pipeline to single-sample and two-sample MR study designs, encompassing diverse populations and a wide range of diseases. Our results demonstrate superior performance compared to existing MR methods. In conclusion, our research presents an integrated MR analysis pipeline that significantly enhances the accuracy and reliability of MR studies. By outperforming existing methods and providing comprehensive validation, this pipeline represents a valuable tool for researchers in genetics and epidemiology.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used ONLY openly available human data that were originally located at: MRC Integrative Epidemiology Unit database and github.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
sharma.51{at}iitj.ac.in (J. Sharma); m22bb006{at}iitj.ac.in (V. Jangale); swain.3{at}iitj.ac.in (A.K. Swain);
Data Availability
All data produced are available online at MRC Integrative Epidemiology Unit database and github.
